Krystal Biotech Inc (NAS:KRYS)
$ 155.995 -6.835 (-4.2%) Market Cap: 4.45 Bil Enterprise Value: 4.12 Bil PE Ratio: 82.98 PB Ratio: 5.57 GF Score: 36/100

Q3 2023 Krystal Biotech Inc Earnings Call Transcript

Nov 06, 2023 / 01:30PM GMT
Release Date Price: $103.77 (-15.05%)
Operator

Thank you for standing by, and welcome to the Krystal Biotech Third Quarter 2023 Earnings Conference Call. As a reminder, today's conference call is being recorded. I would now like to hand the conference over to your host, Meg Dodge, Head of Investor Relations and Corporate Communication. Please begin.

Meg Dodge
Krystal Biotech, Inc. - VP of IR & Corporate Communications

Good morning, and thank you all for joining today's call. Earlier, we released our financial results for the third quarter of 2023. The press release is available on our website at krystalbio.com. Our earnings 8-K was filed earlier today. And additionally, we filed our 10-k with the SEC. Joining me on the call are Krish Krishnan, Chairman and Chief Executive Officer; Suma Krishnan, President of Research and Development; and Kathryn Romano, Chief Accounting Officer. I'd like to note that during this call, we'll be making a number of forward-looking statements about our future business plans, strategies, financial performances and projections, product candidate development plans, including

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot